Improving Congenital Heart Disease Care

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco

About this trial

The theory-informed digital health intervention, called as "Empower My Congenital Health (EmpowerMyCH)" aims to activate and engage ACHD patients in building confidence toward navigating the adult healthcare system. This tool is built after incorporating the theories of behavior change, gathering inputs from target patients in all stages of its design and implementation. The key features of the tool include a digital medical passport, updated congenital information, community support, and patient stories and advice. The investigators aim to test the acceptability, feasibility, efficacy, and effectiveness of the intervention.

Eligibility criteria

Qualifiers

have congenital heart disease

18 years or older

can sign the informed consent

Disqualifiers

developmentally delayed

unable to consent

Trial design

Treatments tested in this trial

  • Digital patient empowerment intervention

Treatment groups

1,000 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of California, San Francisco

Lead sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator